Rain Therapeutics
(NASDAQ:RAIN)
$3.94
At close: Oct 5
$5.29
1.35[34.26%]
PreMarket: 9:29AM EDT
Day Range- - -52 Wk Range2.15 - 14.03Open / Close- / -Float / Outstanding6.5M / 26.6M
Vol / Avg.- / 75.4KMkt Cap104.7MP/E-50d Avg. Price6.34
Div / Yield-Payout Ratio-Total Float6.5MEPS-0.66

Rain Therapeutics Stock (NASDAQ:RAIN), Quotes and News Summary

Rain Therapeutics Stock (NASDAQ: RAIN)

Day Range- - -52 Wk Range2.15 - 14.03Open / Close- / -Float / Outstanding6.5M / 26.6M
Vol / Avg.- / 75.4KMkt Cap104.7MP/E-50d Avg. Price6.34
Div / Yield-Payout Ratio-Total Float6.5MEPS-0.66
Sector: Health Care.Industry: Pharmaceuticals
Rain Therapeutics Inc is a late-stage precision oncology company developing therapies that target oncogenic drivers for which it is able to genetically select patients it believes will likely benefit. This approach includes using a tumor-agnostic strategy to select patients based on their tumors' underlying genetics rather than histology. The company's product candidate, milademetan, is a small molecule, oral inhibitor of MDM2, which is oncogenic in numerous cancers. In addition to milademetan, the company is also developing a preclinical program that is focused on inducing synthetic lethality in cancer cells by inhibiting RAD52.

Earnings

see more
Q3 2022Est.ActualSurprise
EPS
(EXPECTED)2022-11-09
REV
Q2 2022Est.ActualSurprise
EPS-0.660-0.660 0.0000
REV0

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

Rain Therapeutics Questions & Answers

Q
How do I buy Rain Therapeutics (RAIN) stock?
A

You can purchase shares of Rain Therapeutics (NASDAQ: RAIN) through any online brokerage.

View our list of the best stock brokerages.

Q
Who are Rain Therapeutics's (RAIN) competitors?
Q
What is the target price for Rain Therapeutics (RAIN) stock?
A

The latest price target for Rain Therapeutics (NASDAQ: RAIN) was reported by HC Wainwright & Co. on Monday, September 12, 2022. The analyst firm set a price target for 10.00 expecting RAIN to rise to within 12 months (a possible 153.81% upside). 4 analyst firms have reported ratings in the last year.

Q
Current Stock Price for Rain Therapeutics (RAIN)?
A

The stock price for Rain Therapeutics (NASDAQ: RAIN) is $3.94 last updated October 5, 2022, 8:00 PM UTC.

Q
Does Rain Therapeutics (RAIN) pay a dividend?
A

There are no upcoming dividends for Rain Therapeutics.

Q
When is Rain Therapeutics (NASDAQ:RAIN) reporting earnings?
A

Rain Therapeutics’s Q3 earnings are confirmed for Wednesday, November 9, 2022.

Q
Is Rain Therapeutics (RAIN) going to split?
A

There is no upcoming split for Rain Therapeutics.

Q
What sector and industry does Rain Therapeutics (RAIN) operate in?
A

Rain Therapeutics is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.